MMP9 and bronchopulmonary dysplasia: Differential analysis of peripheral blood data from BPD patients in validation set 1 (5 days post-birth) and validation set 2 (14 days post-birth) revealed a significant increase in 5 markers in the BPD group compared to the control group, with the exception of MMP9 in validation set 2.6D, 6G).